Comparative Pharmacology
Head-to-head clinical analysis: MANNITOL 5 versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MANNITOL 5 versus OSMITROL 20 IN WATER IN PLASTIC CONTAINER.
MANNITOL 5% vs OSMITROL 20% IN WATER IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mannitol is an osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into the extracellular fluid and vasculature, thereby reducing intracranial and intraocular pressure. It also increases renal tubular osmotic pressure, inhibiting water reabsorption and promoting diuresis.
Osmotic diuretic that increases plasma osmolality, drawing water from intracellular spaces into extracellular fluid and increasing renal tubular osmotic pressure, thereby inhibiting water reabsorption and promoting diuresis.
Intravenous infusion of 50-100 g (as a 5% solution) over 2-6 hours, typically 500-1000 mL, for osmotic diuresis; or for reduction of intracranial pressure, 1-2 g/kg IV over 30-60 minutes as a 15-25% solution.
0.25-1 g/kg intravenously over 30-60 minutes, repeated every 6-12 hours if needed.
None Documented
None Documented
Terminal: 0.25–1.5 h (prolonged in renal impairment); clinical context: accumulates in renal failure, monitor serum osmolarity and renal function
Terminal elimination half-life is 0.25–1.5 hours in normal renal function; prolonged to 4–6 hours with anuria or oliguria. Clinically, osmotic diuresis lasts as long as urine output sustains concentration.
Renal: 90% unchanged; biliary/fecal: negligible (<2%)
Primarily renal (90-100% unchanged) via glomerular filtration; <3% metabolized in liver; minimal biliary/fecal excretion.
Category A/B
Category C
Osmotic Diuretic
Osmotic Diuretic